WallStSmart
AVDL

Avadel Pharmaceuticals PLC

NASDAQ: AVDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$21.64
+0.00% today

Updated 2026-02-12

Market cap
$2.12B
P/E ratio
0.00
P/S ratio
8.55x
EPS (TTM)
$0.00
Dividend yield
52W range
$6 – $24
Volume
2.2M

Avadel Pharmaceuticals PLC (AVDL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-19.39M$-29.83M$-19.24M$-7.51M$8.20M$-5.46M$-10.32M$-23.14M$-20.68M$-10.62M$84.29M$18.90M$16.66M$-82.72M$-38.33M$-48.73M$-77.31M$-70.30M$-128.51M$-46.91M
Capital expenditures$11.33M$6.39M$11.27M$3.52M$1.77M$3.60M$1.90M$1.07M$1.03M$1.73M$1.63M$1.20M$53.70M$20.18M$29000.00$98000.00$26000.00$716000.00$0.00$0.00
Depreciation
Stock-based comp$1.39M$546000.00$9.99M$8.29M$5.50M$3.17M$2.78M$3.04M$2.03M$2.69M$7.74M$14.68M$8.07M$7.85M$519000.00$3.00M$8.87M$7.01M$15.81M$20.39M
Free cash flow$-30.71M$-36.22M$-30.51M$-11.03M$6.42M$-9.06M$-12.23M$-24.21M$-21.70M$-12.35M$82.66M$17.70M$-37.04M$-102.89M$-38.35M$-48.83M$-77.34M$-71.02M$-128.51M$-46.91M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$25.30M$-25.85M$-22.65M$-7.24M$371000.00$61.23M$-20.12M